Rockefeller Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-973
| Closed | -$14K | – | 3183 |
|
|
2022
Q4 | $14K | Sell |
973
-218
| -18% | -$3.14K | ﹤0.01% | 2933 |
|
|
2022
Q3 | $22K | Buy |
1,191
+97
| +9% | +$1.79K | ﹤0.01% | 2731 |
|
|
2022
Q2 | $19K | Sell |
1,094
-93
| -8% | -$1.62K | ﹤0.01% | 2780 |
|
|
2022
Q1 | $29K | Buy |
1,187
+497
| +72% | +$12.1K | ﹤0.01% | 2568 |
|
|
2021
Q4 | $19K | Sell |
690
-548
| -44% | -$15.1K | ﹤0.01% | 2671 |
|
|
2021
Q3 | $39K | Buy |
1,238
+838
| +210% | +$26.4K | ﹤0.01% | 2259 |
|
|
2021
Q2 | $12K | Sell |
400
-345
| -46% | -$10.4K | ﹤0.01% | 2708 |
|
|
2021
Q1 | $22K | Buy |
745
+345
| +86% | +$10.2K | ﹤0.01% | 2240 |
|
|
2020
Q4 | $7K | Sell |
400
-95
| -19% | -$1.66K | ﹤0.01% | 2342 |
|
|
2020
Q3 | $6K | Buy |
495
+100
| +25% | +$1.21K | ﹤0.01% | 2162 |
|
|
2020
Q2 | $4K | Sell |
395
-472
| -54% | -$4.78K | ﹤0.01% | 2167 |
|
|
2020
Q1 | $12K | Sell |
867
-533
| -38% | -$7.38K | ﹤0.01% | 1687 |
|
|
2019
Q4 | $38K | Buy |
1,400
+300
| +27% | +$8.14K | ﹤0.01% | 1214 |
|
|
2019
Q3 | $31K | Buy |
+1,100
| New | +$31K | ﹤0.01% | 1106 |
|